Articles with the keyword: 


Radical Prostatectomy - Where We Were And Where We Are Going?
kavin submitted, created time 6 months 1 week (www.mphtimes.com)
ORLANDO, FL (UroToday.com) - Dr. Walsh presented the Whitmore Lecture. He discussed the past history of radical prostatectomy (RP). The first RP was performed in 1904 in a perineal approach. The retropubic operation was introduced in 1947. During the Whitmore era, many men did not need to be cured, as they had more comorbidities and died of other causes. Presently, cancer is the leading cause of death in the US. In Whitmore's era, cure was often not possible due to advanced disease and complications for lower risk disease were too high 


treatments of choice in patients with Non-Small Cell Lung Cancer
angelfish submitted, created time 1 year 5 months (www.ro-journal.com)
"In the present study we were able to reproduce the results of EORTC trial 08972/22973 in a non-selected patient population outside of the setting of a randomised trial. Radiotherapy (66 Gy/ 24 fx/ 33 days)combined with either concomitant daily low dose cisplatin or with two neo-adjuvant courses of gemcitabin and cisplatin are effective treatments for patients with locally advanced Non-Small Cell Lung Cancer. The concomitant schedule is also suitable for elderly people with co-morbidity." 


Money issues strain marriage after prostate cancer
Reviver submitted, created time 1 year 6 months (www.reutershealth.com)
Swedish researchers report, for men with prostate cancer, lost work income and increased health care costs can have a damaging effect on their marriage. 


Omega-3 fatty acids may help slow prostate cancer
DanyC submitted, created time 1 year 6 months (news.xinhuanet.com)
A new study in U.S. with mice suggests that a diet high in omega-3 fatty acids found in fish oil and certain types of fish might help slow prostate cancer, media reported Friday. 


Autocrine Prolactin Promotes Prostate Cancer Cell Growth
addict submitted, created time 1 year 6 months (endo.endojournals.org)
Autocrine Prolactin Promotes Prostate Cancer Cell Growth via Janus Kinase-2-Signal Transducer and Activator of Transcription-5a/b Signaling Pathway. The molecular mechanisms that promote progression of localized prostate cancer to hormone-refractory and disseminated disease are poorly understood. Prolactin (Prl) is a local growth factor produced in high-grade prostate cancer, and exogenously added Prl in tissue or explant cultures of normal and malignant prostate is a strong mitogen and survival factor for prostate epithelium 


Aftereffects of prostate cancer treatments vary
captainclaw submitted, created time 1 year 6 months (www.nlm.nih.gov)
Men faced with deciding what prostate cancer treatment to opt for should weigh the fact that surgery, external beam radiation therapy, and radioactive seed implants (brachytherapy) have different effects on subsequent quality of life, according to a report in the medical journal Cancer. 


Alien Interacts with the Human Androgen Receptor and Inhibits Prostate Cancer Cell Growth
addict submitted, created time 1 year 8 months (mend.endojournals.org)
Prostate cancer cell growth is initially androgen dependent. Androgen antagonists are used in prostate cancer therapy to inactivate the transcriptional activity of the human androgen receptor (hAR) and to inhibit the proliferation of prostate cancer. Here, we have characterized Alien with characteristics of a corepressor as a novel interacting factor for the antagonist bound hAR.These findings underline the importance of corepressors for inhibition of prostate cancer cell growth by androgen antagonists. 
\ 1
\